Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Summary by Hastings Tribune
NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-

7 Articles

sherwood.newssherwood.news
Lean Left

Pfizer beats Q4 estimates, releases mid-stage GLP-1 trial results, and maintains guidance for full-year 2026

The company reported Q4 earnings on Tuesday....

Read Full Article
CNBCCNBC
Reposted by
RocketNewsRocketNews
Center

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

The pharmaceutical giant reaffirmed the modest 2026 outlook that rattled investors in December.

·United States
Read Full Article
Hastings TribuneHastings Tribune
+2 Reposted by 2 other sources
Center

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

NEW YORK--(BUSINESS WIRE)--Feb 3, 2026-

Read Full Article
diarioestrategia.cldiarioestrategia.cl

The Us Pharmaceutical Company Pfizer Won 6,586 Million Euros in 2025, 3.2% Less

The US laboratory Pfizer recorded a net assigned profit of 7,771 million dollars (6,586 million euros) in 2025, representing a 3.2% decrease from the result recorded the previous year.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The AI Journal broke the news in on Tuesday, February 3, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Coronavirus icon

Coronavirus

GLP-1 icon

GLP-1

New York City icon

New York City

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal